Kuan-Lin Kuo

907 total citations
28 papers, 758 citations indexed

About

Kuan-Lin Kuo is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Kuan-Lin Kuo has authored 28 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in Kuan-Lin Kuo's work include Ubiquitin and proteasome pathways (10 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Kuan-Lin Kuo is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). Kuan-Lin Kuo collaborates with scholars based in Taiwan, United Kingdom and United States. Kuan-Lin Kuo's co-authors include Kuo‐How Huang, Chung‐Sheng Shi, Wei‐Chou Lin, Shing‐Hwa Liu, Hong‐Chiang Chang, Yeong‐Shiau Pu, Po‐Ming Chow, Yu‐Wei Chang, Guey‐Yueh Shi and Hsi-Min Hsiao and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Kuan-Lin Kuo

27 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kuan-Lin Kuo Taiwan	17	401	212	154	103	95	28	758
Kensuke Kojima Japan	16	493 1.2×	149 0.7×	243 1.6×	91 0.9×	192 2.0×	41	1.1k
Yanjuan He China	15	618 1.5×	207 1.0×	92 0.6×	100 1.0×	310 3.3×	40	1.0k
Maria Grazia Cerrito Italy	19	526 1.3×	251 1.2×	62 0.4×	111 1.1×	137 1.4×	53	1.1k
Mei Ming United States	14	421 1.0×	176 0.8×	243 1.6×	93 0.9×	70 0.7×	29	884
Wenting Liu China	18	512 1.3×	212 1.0×	231 1.5×	264 2.6×	210 2.2×	58	1.3k
Krishnendu Roy United States	13	762 1.9×	133 0.6×	65 0.4×	61 0.6×	72 0.8×	24	1.1k
Fei Yue China	14	649 1.6×	227 1.1×	94 0.6×	114 1.1×	140 1.5×	32	972
Luv Patel United States	12	459 1.1×	221 1.0×	77 0.5×	92 0.9×	77 0.8×	33	877
Anastasia Meshcheryakova Austria	15	381 1.0×	206 1.0×	50 0.3×	228 2.2×	105 1.1×	30	771

Countries citing papers authored by Kuan-Lin Kuo

Since Specialization

Citations

This map shows the geographic impact of Kuan-Lin Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuan-Lin Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuan-Lin Kuo more than expected).

Fields of papers citing papers by Kuan-Lin Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuan-Lin Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuan-Lin Kuo. The network helps show where Kuan-Lin Kuo may publish in the future.

Co-authorship network of co-authors of Kuan-Lin Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Kuan-Lin Kuo. A scholar is included among the top collaborators of Kuan-Lin Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuan-Lin Kuo. Kuan-Lin Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chow, Po‐Ming, Yu‐Wei Chang, Kuan-Lin Kuo, et al.. (2022). The UCHL5 inhibitor b-AP15 overcomes cisplatin resistance via suppression of cancer stemness in urothelial carcinoma. Molecular Therapy — Oncolytics. 26. 387–398. 15 indexed citations

Chow, Po‐Ming, Yu‐Wei Chang, Kuan-Lin Kuo, et al.. (2021). CDK7 inhibition by THZ1 suppresses cancer stemness in both chemonaïve and chemoresistant urothelial carcinoma via the hedgehog signaling pathway. Cancer Letters. 507. 70–79. 11 indexed citations

Hsu, Fu-Shun, June‐Tai Wu, Jing‐Yi Lin, et al.. (2019). Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway. International Journal of Molecular Sciences. 20(5). 1162–1162. 23 indexed citations

Chow, Po‐Ming, Shing‐Hwa Liu, Yu‐Wei Chang, et al.. (2019). The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma. Cancer Letters. 471. 27–37. 24 indexed citations

Kuo, Kuan-Lin, et al.. (2019). Abstract 4439: MLN4924, a protein neddylation inhibitor, elicits antitumor effect via suppression of angiogenesis. Cancer Research. 79(13_Supplement). 4439–4439. 1 indexed citations

Lin, Wei‐Chou, Fu-Shun Hsu, Kuan-Lin Kuo, et al.. (2018). Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma. Journal of Molecular Medicine. 96(12). 1307–1318. 9 indexed citations

Wu, Meng–Huang, Ching‐Yu Lee, Tsung‐Jen Huang, et al.. (2018). MLN4924, a Protein Neddylation Inhibitor, Suppresses the Growth of Human Chondrosarcoma through Inhibiting Cell Proliferation and Inducing Endoplasmic Reticulum Stress-Related Apoptosis. International Journal of Molecular Sciences. 20(1). 72–72. 48 indexed citations

Hsu, Che-Ju, et al.. (2017). The effects of silica nanoparticles on blue-phase liquid crystals. Liquid Crystals. 45(2). 303–309. 18 indexed citations

Chao, Sung‐Chuan, Ying‐Ju Chen, Kuo‐How Huang, et al.. (2017). Induction of sirtuin-1 signaling by resveratrol induces human chondrosarcoma cell apoptosis and exhibits antitumor activity. Scientific Reports. 7(1). 3180–3180. 65 indexed citations

10.

Chen, Wei‐Yu, Yi-Jyun Chen, Kuan-Lin Kuo, et al.. (2016). dBRWD3 Regulates Tissue Overgrowth and Ectopic Gene Expression Caused by Polycomb Group Mutations. PLoS Genetics. 12(9). e1006262–e1006262. 2 indexed citations

11.

Hsieh, Ju‐Ton, Kuan-Lin Kuo, Shing‐Hwa Liu, et al.. (2016). Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis—In Vivo Study. Urology. 91. 242.e1–242.e9. 9 indexed citations

12.

Ho, I-Lin, Kuan-Lin Kuo, Shing‐Hwa Liu, et al.. (2015). MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma. Scientific Reports. 5(1). 16948–16948. 40 indexed citations

13.

Kuo, Kuan-Lin, I-Lin Ho, Chung‐Sheng Shi, et al.. (2015). MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies. Cancer Letters. 363(2). 127–136. 53 indexed citations

14.

Lin, Wei‐Chou, Kuan-Lin Kuo, Chung‐Sheng Shi, et al.. (2015). MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study.. PubMed. 5(11). 3350–62. 22 indexed citations

15.

Kuo, Kuan-Lin, Wei‐Chou Lin, I-Lin Ho, et al.. (2013). 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells. PLoS ONE. 8(8). e68703–e68703. 25 indexed citations

16.

Huang, Kuo‐How, Kuan-Lin Kuo, I-Lin Ho, et al.. (2013). Celecoxib-Induced Cytotoxic Effect Is Potentiated by Inhibition of Autophagy in Human Urothelial Carcinoma Cells. PLoS ONE. 8(12). e82034–e82034. 20 indexed citations

17.

Huang, Kuo‐How, Kuan-Lin Kuo, Shyh-Chyan Chen, et al.. (2012). Down-Regulation of Glucose-Regulated Protein (GRP) 78 Potentiates Cytotoxic Effect of Celecoxib in Human Urothelial Carcinoma Cells. PLoS ONE. 7(3). e33615–e33615. 32 indexed citations

18.

Lin, Wei‐Chou, et al.. (2011). Stathmin Immunoreactivity in Phaeochromocytomas and Paragangliomas: Differential Expression Between Benign and Malignant Neoplasms. Asian Journal of Surgery. 34(1). 15–22. 2 indexed citations

19.

Wu, Chung-Chun, Ming‐Tsan Liu, Yu‐Ting Chang, et al.. (2009). Epstein–Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells. Nucleic Acids Research. 38(6). 1932–1949. 75 indexed citations

20.

Shi, Chung‐Sheng, Guey‐Yueh Shi, Hsi-Min Hsiao, et al.. (2008). Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood. 112(9). 3661–3670. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact